Terms: = Gastric cancer AND CDK12, KIAA0904, CRKRS, 51755, ENSG00000167258, CRK7, CRKR, Q9NYV4 AND Treatment
6 results:
1. Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial.
Hu Q; Oki E; Yamada T; Kashiwada T; Sonoda H; Kataoka M; Kawanaka H; Tsuji Y; Makiyama A; Nakashima Y; Ota M; Kimura Y; Yoshizumi T
Cancer Med; 2023 Aug; 12(15):16649-16660. PubMed ID: 37325934
[TBL] [Abstract] [Full Text] [Related]
2. cdk12 Promotes the Proliferation, Migration, and Angiogenesis of gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway.
Gao LZ; Wang JQ; Chen JL; Zhang XL; Zhang MM; Wang SL; Zhao C
Appl Biochem Biotechnol; 2023 Nov; 195(11):6913-6926. PubMed ID: 36951936
[TBL] [Abstract] [Full Text] [Related]
3. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive analysis of metastatic gastric cancer tumour cells using single-cell RNA-seq.
Wang B; Zhang Y; Qing T; Xing K; Li J; Zhen T; Zhu S; Zhan X
Sci Rep; 2021 Jan; 11(1):1141. PubMed ID: 33441952
[TBL] [Abstract] [Full Text] [Related]
5. cdk12 and PAK2 as novel therapeutic targets for human gastric cancer.
Liu H; Shin SH; Chen H; Liu T; Li Z; Hu Y; Liu F; Zhang C; Kim DJ; Liu K; Dong Z
Theranostics; 2020; 10(14):6201-6215. PubMed ID: 32483448
[No Abstract] [Full Text] [Related]
6. cdk12: an emerging therapeutic target for cancer.
Lui GYL; Grandori C; Kemp CJ
J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
[TBL] [Abstract] [Full Text] [Related]
